Results 221 to 230 of about 9,104 (252)

Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users

Contemporary Drug Problems, 2019
Hannes Kettner, Natasha L Mason, Kim P C Kuypers   +2 more
exaly  

Availability and supply of novel psychoactive substances

2022
Arie P. Francis, Silas W. Smith
openaire   +1 more source

Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill

Addiction, 2017
Peter Reuter, Bryce Pardo
exaly  

Novel psychoactive substances and inhalants

2019
Roger Bloor, Xenofon Sgouros
openaire   +1 more source

Death cases involving certain new psychoactive substances: A review of the literature

Forensic Science International, 2019
Michael Kramer, Burkhard Madea, Alexandra Maas   +2 more
exaly  

Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act

Clinical Toxicology, 2019
David M Wood, Shaun L Greene, John R H Archer   +2 more
exaly  

Monitoring Novel Psychoactive Substances

2013
Roumen Sedefov, Ana Gallegos, Jane Mounteney, Padraigin Kenny   +3 more
openaire   +1 more source

Pharmacological profiling of novel psychoactive substances

2022
Matthias E. Liechti, Linda D. Simmler, Harald H. Sitte, Dino Luethi   +3 more
openaire   +1 more source

New psychoactive substances: Are there any good options for regulating new psychoactive substances?

International Journal of Drug Policy, 2017
Peter Reuter, Bryce Pardo
exaly  

Metabolomics predicts the pharmacological profile of new psychoactive substances

Journal of Psychopharmacology, 2019
Eulalia Olesti, Ilario De Toma, Johannes G Ramaekers   +2 more
exaly